164 related articles for article (PubMed ID: 38361235)
1. Marginal Zone B Cells Are Necessary for the Formation of Anti-donor IgG After Allogeneic Sensitization.
Kallarakal MA; Cohen GS; Ibukun FI; Krummey SM
Transplantation; 2024 Jun; 108(6):1357-1367. PubMed ID: 38361235
[TBL] [Abstract][Full Text] [Related]
2. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
Wray DW; Baldwin WM; Sanfilippo F
Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
[TBL] [Abstract][Full Text] [Related]
3. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
4. Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice.
Zerra PE; Patel SR; Jajosky RP; Arthur CM; McCoy JW; Allen JWL; Chonat S; Fasano RM; Roback JD; Josephson CD; Hendrickson JE; Stowell SR
Blood; 2021 Aug; 138(8):706-721. PubMed ID: 33876205
[TBL] [Abstract][Full Text] [Related]
5. Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig.
Chen J; Yin H; Xu J; Wang Q; Edelblum KL; Sciammas R; Chong AS
Am J Transplant; 2013 Sep; 13(9):2280-92. PubMed ID: 23855587
[TBL] [Abstract][Full Text] [Related]
6. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
[TBL] [Abstract][Full Text] [Related]
7. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
[TBL] [Abstract][Full Text] [Related]
8. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
ten Hoor GM; Coopmans M; Allebes WA
Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
[TBL] [Abstract][Full Text] [Related]
9. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3038. PubMed ID: 30728823
[TBL] [Abstract][Full Text] [Related]
10. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.
Itescu S; Tung TC; Burke EM; Weinberg A; Moazami N; Artrip JH; Suciu-Foca N; Rose EA; Oz MC; Michler RE
Circulation; 1998 Aug; 98(8):786-93. PubMed ID: 9727549
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
Yang TY; Sun Y; Langnas AN; Zhao Y
Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
[TBL] [Abstract][Full Text] [Related]
12. Murine complement receptor 1 is required for germinal center B cell maintenance but not initiation.
Donius LR; Weis JJ; Weis JH
Immunobiology; 2014 Jun; 219(6):440-9. PubMed ID: 24636730
[TBL] [Abstract][Full Text] [Related]
13. Two levels of help for B cell alloantibody production.
Steele DJ; Laufer TM; Smiley ST; Ando Y; Grusby MJ; Glimcher LH; Auchincloss H
J Exp Med; 1996 Feb; 183(2):699-703. PubMed ID: 8627185
[TBL] [Abstract][Full Text] [Related]
14. Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens.
Blazar BR; Taylor PA; Bluestone JA; Vallera DA
Blood; 1996 May; 87(10):4463-72. PubMed ID: 8639809
[TBL] [Abstract][Full Text] [Related]
15. Positive selection of IgG
Sundling C; Lau AWY; Bourne K; Young C; Laurianto C; Hermes JR; Menzies RJ; Butt D; Kräutler NJ; Zahra D; Suan D; Brink R
Immunity; 2021 May; 54(5):988-1001.e5. PubMed ID: 33857421
[TBL] [Abstract][Full Text] [Related]
16. T cell-dependent IgM memory B cells generated during bacterial infection are required for IgG responses to antigen challenge.
Yates JL; Racine R; McBride KM; Winslow GM
J Immunol; 2013 Aug; 191(3):1240-9. PubMed ID: 23804710
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
19. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
20. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
